Day: March 7, 2023

Weebit Nano partners with University of Florida’s Nino Research Group to examine effects of radiation on Weebit ReRAM

Written by Customer Service on March 7, 2023. Posted in Public Companies.

Initial studies confirm ReRAM’s tolerance to high levels of gamma radiation HOD HASHARON, Israel, March 07, 2023 (GLOBE NEWSWIRE) — Weebit Nano Limited (ASX:WBT), a leading developer of advanced memory technologies for the global semiconductor industry, is partnering with the Nino Research Group (NRG) in the University of Florida’s Department of Materials Science and Engineering to study the effects of radiation on Weebit’s resistive random access memory (ReRAM) technology. Results of initial studies confirm Weebit ReRAM arrays are tolerant to high radiation levels. Being conducted by NRG, Weebit, and Weebit’s R&D partner CEA-Leti, initial studies show that Weebit ReRAM maintains data integrity and memory functionality after being subjected to doses of gamma irradiation exceeding the most demanding requirements. The...

Better Choice to Announce Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023

Written by Customer Service on March 7, 2023. Posted in Public Companies.

NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) — Better Choice Company Inc. (AMEX: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it will release its fourth quarter and full year 2022 financial results on Tuesday, March 28, 2023. Additional details are available on the Company’s website: https://betterchoicecompany.com/. About Better Choice Company, Inc.Better Choice Company Inc. is a pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. We offer a broad portfolio of pet health and wellness products for dogs and cats sold under our Halo brand across multiple forms, including foods, treats, toppers, dental products, chews, and supplements. We have a demonstrated, multi-decade track record of success...

F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma

Written by Customer Service on March 7, 2023. Posted in Mergers And Acquisitions.

Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender Offer CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 07, 2023 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc. (NASDAQ: FSTX) (“F-star” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer, today announced that the Committee on Foreign Investment in the United States (“CFIUS”) has cleared the previously announced all-cash acquisition of the Company by invoX Pharma Limited (“invoX”). The CFIUS clearance satisfies the Foreign Investment Condition of the ongoing tender offer (the “Offer”), and is the final required regulatory approval needed to complete the proposed merger. As described below, the parties expect...

Aura to deliver 525 of its new 10 kW axial flux induction mobile power solutions

Written by Customer Service on March 7, 2023. Posted in Public Companies.

LAKE FOREST, CALIFORNIA , March 07, 2023 (GLOBE NEWSWIRE) — Aura Systems Inc. (Symbol “AUSI”) announced today that it has entered into an exclusive distribution agreement with Hippo Multipower to provide a minimum of 525 of Aura’s new 10 kW AuraGen® mobile power application for use on various models of Polaris® ultralight tactical military MRZR vehicles and derivatives such as the MRZR D2 and D4 and the MRZR Alpha over a three-year period. The minimum value of the agreement over the three years is approximately $8.85 million. The first delivery of 10 kW AuraGen® systems under this contract is currently scheduled to take place by June 1, 2023. “Hippo is very excited to be able to offer the AuraGen® power solution for Polaris MRZR and derivatives such as the MRZR D2 and D4 and the MRZR Alpha military platforms. There are currently...

APPlife Digital Solutions, Inc. Signs Strategic Partnership with 3PL Service Provider, Premier Shipping and Fulfillment LLC

Written by Customer Service on March 7, 2023. Posted in Public Companies.

SAN FRANCISCO, March 07, 2023 (GLOBE NEWSWIRE) — APPlife Digital Solutions, Inc. (OTCQB: ALDS) (“APPlife”, the Company”), a business incubator and portfolio manager that invests in and creates e-commerce and cloud-based solutions announced today that it has signed a strategic partnership with Premier Shipping and Fulfillment LLC (“Premier”), a 3PL services provider. Established in 2018, Premier Shipping and Fulfillment LLC is a growing Swedesboro, N.J.-based logistics company whose mission is to provide outstanding services and build a logistics network that surpasses expectations. Currently, their services include order fulfillment, pick, pack & ship, custom software development, and marketplace integration. APPlife already principally utilizes Premier’s pick, pack & shipping services to fulfill customer orders received...

ZyVersa Therapeutics Adds Dr. Richard J. Glassock to Its Renal Scientific Advisory Board to Support Clinical Advancement of Renal Cholesterol Efflux Mediator™ VAR 200

Written by Customer Service on March 7, 2023. Posted in Public Companies.

Cholesterol Efflux Mediator VAR 200 is a phase 2a-ready drug in development to ameliorate renal lipid accumulation that damages the kidneys’ filtration system, leading to progression of kidney diseaseWESTON, Fla., March 07, 2023 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, announces that Dr. Richard J. Glassock has joined ZyVersa’s Renal Scientific Advisory Board. “We are honored that Dr. Glassock, an internationally recognized authority in the field of glomerular disease, is joining our Scientific Advisory Board,” stated Dr. Pablo Guzman, ZyVersa’s Chief Medical Officer and Chairman of the Renal Scientific Advisory Board....

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

Written by Customer Service on March 7, 2023. Posted in Public Companies.

Marks the eighth advisor to growing KOL program to build strong body of clinical evidence and support US commercialization Aclarion to participate in upcoming SPINEWEEK 2023 Broomfield, CO, March 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that Alpesh Patel, MD, MBA Co-Director of Northwestern Center for Spine Health will advise the company as a key opinion leader (KOL). In addition to his leadership role in the Center for Spine Health, Dr. Patel serves as professor of Orthopaedic Surgery and Neurosurgery at Northwestern University in Evanston, IL. Chronic low back...

Cyclacel Pharmaceuticals to Participate in March Investor Conferences

Written by Customer Service on March 7, 2023. Posted in Public Companies.

BERKELEY HEIGHTS, N.J., March 07, 2023 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced today that the Company plans to participate in a fireside chat and host one-on-one meetings at two investor conferences. Oppenheimer 33rd Annual Healthcare Conference:Location: VirtualFormat: Fireside chat and one-on-one meetingsDate: March 13-15, 2023Fireside chat: March 13, 10:00am ETPresenter: Spiro RombotisWebcast: Link35th Annual Roth Conference:Location: Dana Point, CAFormat: Fireside chat and one-on-one meetingsDate: March 12-14, 2023Fireside chat: March 13, 3:00pm PTPresenter: Paul McBarronWebcast: LinkAbout Cyclacel...

Nano Dimension Receives Another Purchase Order for DragonFly IV® system from a Western Intelligence Agency

Written by Customer Service on March 7, 2023. Posted in Public Companies.

Over 10 Defense and Intelligence Agencies Served by the Company Waltham, Mass., March 07, 2023 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, announced today that it has received a purchase order from a leading Western intelligence agency, for a DragonFly IV® system, the leading Additive Manufacturing Electronics (AME) 3D-printer. For reasons of national security, Nano Dimension cannot reveal the name of the country where the intelligence agency is situated, but this is clearly a continuation of the Company’s success in providing leading technology to those who need it most. This intelligence agency, and others like it, which...

Nano Dimension (“NANO”) Reiterates that Shareholder Meeting Called by Murchinson Ltd. is Illegal & Invalid. Urges Shareholders to:

Written by Customer Service on March 7, 2023. Posted in Public Companies.

Ignore Bistricer/Murchinson Ltd.’s Misinformation Campaign Disregard Murchinson/Bistricer Proxy Voting Materials No Shareholder Action Is Required at This Time Company Will Inform Shareholders If and When a Valid and Duly Called Shareholder Meeting Will be Held.NANO filed a lawsuit seeking a declaratory judgment that the Bistricer/Murchinson’s meeting is illegal and seeking $10 million damages in relation to their illegal and bad faith actions. Waltham, Mass, March 07, 2023 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, today reiterated that the shareholder meeting called by Bistricer/Murchinson Ltd. (“Bistricer/Murchinson”)...

Day: March 7, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice